ゲーレゲレゲレゲレゲレ! 0223名無しさん@お腹いっぱい。2024/05/08(水) 08:56:00.28 アステラス頑張れ! 0224名無しさん@お腹いっぱい。2024/05/08(水) 08:56:37.93 外資に負けるな! 0225名無しさん@お腹いっぱい。2024/05/08(水) 10:52:34.13 パテントクリフを舐めすぎ。 2年後、どうなってる? 想像するだけで恐怖だわ。 0226名無しさん@お腹いっぱい。2024/05/08(水) 12:00:13.75 清水智仁って知ってる? 0227名無しさん@お腹いっぱい。2024/05/11(土) 11:09:48.85 増配しても株価が下がり続ける無限地獄のフェーズに突入したか。4連続下方修正で経営者とIRの信頼は地に堕ちて、イクスタンジの特許切れる前にもはや崖っぷちだな。 0228名無しさん@お腹いっぱい。2024/05/11(土) 19:48:10.13>>227 Astellas Pharma has indeed faced a series of downward revisions, leading to a significant drop in stock price. However, it is important to consider the broader context of the pharmaceutical industry and the company’s strategic moves to address these challenges.
Firstly, the pharmaceutical industry is inherently cyclical and subject to various external factors such as patent expirations, regulatory changes, and market competition. Astellas Pharma’s experience with the patent expiration of Xtandi is not unique and is a part of the industry’s natural ebb and flow. The company has been proactive in seeking new revenue streams to mitigate the impact of such patent cliffs.
Secondly, Astellas Pharma’s recent acquisitions and investments in research and development signal a commitment to innovation and long-term growth. The company’s strategy includes diversifying its portfolio and enhancing its pipeline with potential blockbusters in various therapeutic areas.
Lastly, while the stock price reflects investor sentiment in the short term, it may not fully capture the company’s future value. Astellas Pharma’s efforts to strengthen its product lineup and expand into new markets are steps towards ensuring sustainability and profitability in the long run.
In conclusion, while the current phase may seem challenging, Astellas Pharma is taking necessary actions to secure its position in the pharmaceutical landscape. The company’s resilience and strategic planning warrant a more optimistic outlook for its future.
This response aims to provide a balanced view of the situation, acknowledging the challenges while also highlighting the company’s strategies to overcome them. It’s important to remember that the pharmaceutical industry is complex and dynamic, and companies like Astellas Pharma are continuously adapting to maintain their competitive edge. 0229警備員[Lv.7][初]2024/05/11(土) 20:06:36.32 ChatGPTかな 0230名無しさん@お腹いっぱい。2024/05/12(日) 10:14:35.34 グローバル水準のスキルレベルがトップ製薬企業では必要とされる要素なんですね 0231名無しさん@お腹いっぱい。2024/05/12(日) 12:30:06.66 これはワールドワイディー⭐︎智仁が活躍できるな 0232名無しさん@お腹いっぱい。2024/05/12(日) 13:01:39.52 パテントクリフは少なくとも今じゃないでしょ、まだ先なんでしょ? 0233名無しさん@お腹いっぱい。2024/05/12(日) 14:33:32.00 ここはリストラしないのかね? 0234警備員[Lv.2][新初]2024/05/13(月) 01:32:58.27 人でも何でも現金化してもらわないと 0235名無しさん@お腹いっぱい。2024/05/13(月) 08:46:37.98 導入でも売れればいいんだよ 0236名無しさん@お腹いっぱい。2024/05/14(火) 00:21:51.91 旧御三家頑張れ! 0237名無しさん@お腹いっぱい。2024/05/14(火) 03:13:09.19 鱗とDSだけでよい